Document ID: chunk:federal_register_of_legislation:C2024C00484:front:0:p2
Version: federal_register_of_legislation:C2024C00484
Segment Type: other
Provision Reference: 
Character Range: 2753–5411

Application and modification of the Repatriation Private Patient Principles
18 Application and modification of Repatriation Pharmaceutical Benefits Scheme
Part 3—Travelling expenses
19 Entitlement to travelling expenses
20 Advances of travelling expenses
21 Claims for travelling expenses
22 Withdrawal of claims
23 Determination of claims
Part 3A—Pharmaceutical supplement
23A Simplified outline
23B Eligibility for pharmaceutical supplement
23C Pharmaceutical supplement not payable in some circumstances
23D Rate of pharmaceutical supplement
23E Payment of pharmaceutical supplement
Part 4—Review of decisions
Division 1—Review by Commission
24 Request for review
25 Review by Commission
26 Commission must make written record of review decision and reasons
27 Person who requested review to be notified of decision
28 Withdrawal of request for review
Division 2—Review by Administrative Review Tribunal
29 Review by Administrative Review Tribunal
Part 5—Administration and enforcement
Division 1—General
30 Additional functions of Commission
31 Commission not bound by technicalities
32 Delegation
Division 2—Obtaining and giving information etc.
33 Commission may obtain information etc.
34 Failure to comply with a notice
35 Self‑incrimination
36 Giving information
Division 3—Offences
37 False or misleading statements or documents relating to treatment
38 Medical service providers causing detriment to others
39 Medical service providers threatening detriment
40 Bribery by medical service providers
41 Practitioners receiving bribes etc.
42 Pathology practitioners making payments to requesting practitioners
43 Pathology practitioners providing pathology services to persons with whom they have arrangements
44 Providing staff to be used in pathology services
45 Counselling statements inadmissible as evidence
Division 4—Recovery of amounts paid because of false or misleading statements
46 Recovery of amounts paid because of false or misleading statements
47 Interest payable on amounts paid because of false or misleading statements
48 Reduction in payments because of previous overpayments
Division 5—Recovery of cost of treatment
48A Recovery of cost of treatment
Division 6—Recovery of overpayments of pharmaceutical supplement
48B Recovery of overpayments of pharmaceutical supplement
Part 6—Miscellaneous
49 Appropriation
50 Regulations
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history

An Act to provide for treatment for Australian participants in British nuclear tests and in the British Commonwealth Occupation Force, and for other purposes

Part 1—Preliminary